Collateral for a security interest recorded Jan 25, 2024 (Citizens Bank, N.A.).
Term ends Mar 21, 2032 · High confidence
20-year base term ends May 11, 2031
Held by MiMedx Group, Inc.
Filed May 11, 2011 as application 13/105,353 · Granted Apr 14, 2015
Base term plus 315 days of patent term adjustment (USPTO delay)
Today
2011
2032
Clock starts
May 11, 2011
May 11, 2011
Term ends
Mar 21, 2032
Mar 21, 2032
Granted
Apr 14, 2015
Apr 14, 2015
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
315
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
24
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 315 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 11, 2011, when this application, 13/105,353, was filed | May 11, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +315 days, USPTO patent term adjustment record | Mar 21, 2032 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 21, 2032 | High confidence |
This family
| US 9,681,869 | In force Jan 2033 | Jan 2033 |
| US 9,216,077 | In force Mar 2032 | Mar 2032 |
| US 9,078,775 | In force Feb 2032 | Feb 2032 |
| US 8,367,148 | In force Dec 2030 | Dec 2030 |
| US 9,005,285 | this patent Mar 2032 | Mar 2032 |
| US 9,179,976 | In force Jan 2031 | Jan 2031 |
| Application PCT/US2011/039375 | PCT application no patent term | no patent term |
| Application PCT/US2012/027366 | PCT application no patent term | no patent term |
8 of 24 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 28, 2011 Reel 26670, frame 517 | Hernandez, Daniel; Koob, Thomas J. | MiMedx, Inc. | Assignment of Assignor's Interest |
| Jul 28, 2011 Reel 26670, frame 685 | Niu, Mei | MiMedx, Inc. | Assignment of Assignor's Interest |
| Feb 6, 2015 Reel 34906, frame 364 | MiMedx, Inc. | MiMedx Group, Inc. | Assignment of Assignor's Interest |
| Oct 15, 2015 Reel 36872, frame 498 | MiMedx Group, Inc. | Bank of America, N.A., as Administrative Agent | Notice of Grant of Security Interest in Patents |
| Jan 24, 2019 Reel 48121, frame 835 | Bank of America, N.A., as Administrative Agent | MiMedx Group, Inc. | Termination and Release of Security Interest in Patents |
| Jun 11, 2019 Reel 49426, frame 863 | MiMedx Group, Inc. | Blue Torch Finance LLC, as Collateral Agent | Security Interest |
| Jul 2, 2020 Reel 53121, frame 833 | MiMedx Group, Inc.; MiMedx Processing Services, LLC | Hayfin Services LLP, as Collateral Agent | Patent Security Agreement |
| Jul 2, 2020 Reel 54075, frame 687 | Blue Torch Finance LLC, as Collateral Agent | MiMedx Group, Inc.; MiMedx Processing Services, LLC | Release of Security Interest |
| Jul 2, 2020 reel/frame not recorded | Blue Torch Finance LLC, as Collateral Agent | MiMedx Group, Inc. | Release of Security Interest |
| Jul 2, 2020 reel/frame not recorded | Blue Torch Finance LLC, as Collateral Agent | MiMedx Processing Services, LLC | Release of Security Interest |
| Jan 25, 2024 Reel 66250, frame 132 | MiMedx Group, Inc. | Citizens Bank, N.a. | Security Interest |
| Feb 5, 2024 Reel 66493, frame 322 | Hayfin Services LLP | MiMedx Group, Inc.; MiMedx Processing Services, LLC | Release of Security Interest |
| Feb 5, 2024 reel/frame not recorded | Hayfin Services LLP | MiMedx Group, Inc. | Release of Security Interest |
| Feb 5, 2024 reel/frame not recorded | Hayfin Services LLP | MiMedx Processing Services, LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2032
Term ends Mar 21, 2032. No further fees fall due before then
Note
The 315 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
27
later US patents cite this one
That is top 25% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.